Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists
- PMID: 20179794
- PMCID: PMC2826264
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists
Abstract
The Review is a welcome and up-to-date consensus statement on the use of vancomycin. Although many of the points are pertinent to Australasian practice, the clinical context may be subtly different such that different recommendations apply here. It is thus an apt time for clinical, biochemical, pharmacological and pathology staff in Australasia to collaborate and discuss the literature with particular relevance to establishing guidelines for an Australasian context. The new TG (Version 14) will be an interesting update in the antibiotic TDM area and we hope it will be used as a springboard for Australasian clinical research into this area.
Similar articles
-
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.Pharmacotherapy. 2009 Nov;29(11):1275-9. doi: 10.1592/phco.29.11.1275. Pharmacotherapy. 2009. PMID: 19873687 Review.
-
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303. Clin Infect Dis. 2020. PMID: 32658968
-
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877. Clin Infect Dis. 2009. PMID: 19569969
-
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057. J Pediatric Infect Dis Soc. 2020. PMID: 32659787 Free PMC article. No abstract available.
-
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434. Am J Health Syst Pharm. 2009. PMID: 19106348 Review. No abstract available.
Cited by
-
A descriptive study of vancomycin use at Red Cross War Memorial Children's Hospital, Cape Town.S Afr J Infect Dis. 2023 Nov 6;38(1):528. doi: 10.4102/sajid.v38i1.528. eCollection 2023. S Afr J Infect Dis. 2023. PMID: 38058658 Free PMC article.
-
Vancomycin and daptomycin modulate the innate immune response in a murine model of LPS-induced sepsis.Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211031373. doi: 10.1177/20587384211031373. Int J Immunopathol Pharmacol. 2021. PMID: 34296627 Free PMC article.
-
Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA).Springerplus. 2016 Feb 18;5:124. doi: 10.1186/s40064-016-1778-4. eCollection 2016. Springerplus. 2016. PMID: 26933623 Free PMC article.
-
Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.Eur J Drug Metab Pharmacokinet. 2019 Dec;44(6):807-816. doi: 10.1007/s13318-019-00568-6. Eur J Drug Metab Pharmacokinet. 2019. PMID: 31301023
-
A Successful Experience of Individualized Vancomycin Dosing in Critically Ill Patients by Using a Loading Dose and Maintenance Dose.Pharmaceuticals (Basel). 2025 May 2;18(5):677. doi: 10.3390/ph18050677. Pharmaceuticals (Basel). 2025. PMID: 40430496 Free PMC article.
References
-
- Ingram PR, Lye DC, Tambyah PA, Goh WP, Tam VH, Fisher DA. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. J Antimicrob Chemother. 2008;62:168–71. - PubMed
-
- Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82–98. - PubMed
-
- Australian Medicines Handbook. [(Accessed 29 May 2009)]. http://www.amh.net.au.
-
- Therapeutic Guidelines (eTG) [(Accessed 6 April 2009)]. http://www.tg.org.au.
-
- Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy. 2007;27:1081–91. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous